Analog Devices Appoints Dr. Yoky Matsuoka to Board, Enhancing Innovation and Human-Centric Focus

Analog Devices Expands Board with Appointment of Dr. Yoky Matsuoka

Analog Devices, Inc. (Nasdaq: ADI) announces the appointment of Dr. Yoky Matsuoka to its Board of Directors, effective January 20, 2026. This strategic move not only expands the board to 11 members but also brings in a wealth of experience that aligns closely with ADI's commitment to innovation in the fields of technology and human-centric systems. Dr. Matsuoka currently serves as an executive officer at Panasonic Holdings, where she leads global innovation and new business initiatives, a background that positions her well to contribute to ADI's vision.

Dr. Matsuoka's impressive career spans multiple high-profile roles, including Vice President at Google’s healthcare organization and Chief Technology Officer at Google/Nest. She co-founded Google X, the company's research and development lab, which is known for its pioneering projects in technology. Her experience also includes a senior executive role at Apple and the founding of Quanttus, a startup focused on wearable health technology. These roles highlight her unique ability to integrate hardware, software, and artificial intelligence, a skill set that aligns with ADI's mission to create efficient and sustainable systems that enhance human outcomes.

Beyond her corporate achievements, Dr. Matsuoka’s background in academia adds depth to her candidacy. As a former professor at Carnegie Mellon University and the University of Washington, she founded significant research initiatives in sensorimotor neural engineering and neurobotics. Her contributions to the fields of robotics and neuroscience have earned her numerous accolades, including the MacArthur Genius Award. Dr. Matsuoka's dedication to using technology to improve human capabilities is further exemplified through her establishment of the YokyWorks Foundation, which aids children with physical and learning challenges. Her extensive knowledge and experience are expected to guide ADI's strategic direction in merging advanced technologies with everyday applications.

In addition to her role at ADI, Dr. Matsuoka's diverse background in both corporate leadership and academic research provides a holistic perspective that is increasingly necessary in today's technology landscape. Her appointment is a clear indication of ADI's commitment to fostering innovation and human-centric solutions.

The integration of Dr. Matsuoka into ADI's board reflects a broader trend within the technology sector, where companies seek leaders who can navigate the complexities of digital transformation while remaining focused on enhancing human capabilities. As ADI continues to advance its mission, Dr. Matsuoka's insights will likely play a crucial role in shaping the company’s strategic initiatives.